496 related articles for article (PubMed ID: 36380667)
1. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
[No Abstract] [Full Text] [Related]
2. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
[TBL] [Abstract][Full Text] [Related]
3. [The modulatory activity of T cell immunoglobulin and mucin domain-containing protein 3 on T lymphocytes in patients with chronic heart failure].
Yu HW; Dong YY; Dang YH
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1315-1319. PubMed ID: 32375439
[No Abstract] [Full Text] [Related]
4. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic analysis of tuberculosis specific mononuclear cells in peripheral blood of HIV patients with tuberculosis].
Zou S; Zhu Q; Guo YN; Xiang PZ; Mo GL; Chen JH; Liu K; Liang K
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Nov; 45(11):1109-1116. PubMed ID: 36344228
[No Abstract] [Full Text] [Related]
6. Interleukin-9-secreting CD4
Gang H; Peng D; Hu Y; Tang S; Li S; Huang Q
APMIS; 2021 Feb; 129(2):91-102. PubMed ID: 33113251
[TBL] [Abstract][Full Text] [Related]
7. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
8. [Effect of interleukin-7 on the anti-tumor function of CD8(+) T cells in patients with non-small cell lung cancer].
Zhang XH; Wang HM; Jin L; Chang R; Zu FC; Li FZ; Ku CY
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2429-2433. PubMed ID: 30138989
[No Abstract] [Full Text] [Related]
9. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
Zhang YX; Wang XY; Liu JB; Zhang SQ; Chen YR
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):973-6. PubMed ID: 18756970
[TBL] [Abstract][Full Text] [Related]
10. Th9 cells are subjected to PD-1/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer.
Wang C; Lu Y; Chen L; Gao T; Yang Q; Zhu C; Chen Y
Int Immunopharmacol; 2020 Jan; 78():106019. PubMed ID: 31776089
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 and -12 synergistically enhance cytotoxic functions of tumor-infiltrating lymphocytes.
Chen ZF; Zhou R; Xia B; Deng CS
Chin Med J (Engl); 2012 Dec; 125(23):4245-8. PubMed ID: 23217394
[TBL] [Abstract][Full Text] [Related]
12. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
13. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis].
Hou HR; Pan HH; Li YK; Wei JF; Kang YH; Mao CS; Shang J; Kang Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):274-280. PubMed ID: 31082338
[No Abstract] [Full Text] [Related]
15. A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis.
Tsiogkas SG; Mavropoulos A; Dardiotis E; Zafiriou E; Bogdanos DP
Clin Exp Immunol; 2022 Oct; 210(1):79-89. PubMed ID: 35925616
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
[TBL] [Abstract][Full Text] [Related]
19. Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer.
You FP; Zhang J; Cui T; Zhu R; Lv CQ; Tang HT; Sun DW
Int Immunopharmacol; 2017 Nov; 52():163-167. PubMed ID: 28918288
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
Zhang Q; Yang L; Liu S; Zhang M; Jin Z
Front Immunol; 2021; 12():645835. PubMed ID: 34177894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]